NANOG and breast carcinoma: CXCL12 overexpression induces EMT in breast cancer cells, activating stem cell-associated genes like SOX2, OCT4, and NANOG, promoting a stem-like phenotype marked by ALDH1 expression and Wnt/β-catenin pathway activation [194].